These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8226141)

  • 1. Neutron vs. photon radiation therapy for inoperable regional non-small cell lung cancer: results of a multicenter randomized trial.
    Koh WJ; Krall JM; Peters LJ; Maor MH; Laramore GE; Burnison CM; Davis LW; Zink S; Griffin TW
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):499-505. PubMed ID: 8226141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical trials of neutron radiotherapy in the United States.
    Lindsley KL; Cho P; Stelzer KJ; Koh WJ; Austin-Seymour M; Russell KJ; Laramore GE; Griffin TW
    Bull Cancer Radiother; 1996; 83 Suppl():78s-86s. PubMed ID: 8949756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study.
    Livingston RB; Griffin BR; Higano CS; Laramore GE; Rivkin SE; Goldberg RS; Schulman SF
    J Clin Oncol; 1987 Nov; 5(11):1716-24. PubMed ID: 2824705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fast neutron and mixed beam radiotherapy for inoperable non-small cell carcinoma of the lung. Results of an RTOG randomized study.
    Laramore GE; Bauer M; Griffin TW; Thomas FJ; Hendrickson FR; Maor MH; Griffin BR; Saxton JP; Davis LW
    Am J Clin Oncol; 1986 Jun; 9(3):233-43. PubMed ID: 3728375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
    Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.
    Sibley GS; Jamieson TA; Marks LB; Anscher MS; Prosnitz LR
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):149-54. PubMed ID: 9422571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fast neutron radiation therapy. Results of phase III randomized trials in head and neck, lung, and prostate cancers.
    Koh WJ; Griffin TW; Laramore GE; Stelzer KJ; Russell KJ
    Acta Oncol; 1994; 33(3):293-8. PubMed ID: 8018358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast-neutron therapy in advanced head and neck cancer: a collaborative international randomized trial.
    Maor MH; Errington RD; Caplan RJ; Griffin TW; laramore GE; Parker RG; Burnison M; Stetz J; Zink S; Davis LW
    Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):599-604. PubMed ID: 7790244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council.
    Laramore GE; Krall JM; Griffin TW; Duncan W; Richter MP; Saroja KR; Maor MH; Davis LW
    Int J Radiat Oncol Biol Phys; 1993 Sep; 27(2):235-40. PubMed ID: 8407397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N2 (clinical) non-small cell carcinoma of the lung: prospective trials of radiation therapy with total doses 60 Gy by the Radiation Therapy Oncology Group.
    Cox JD; Azarnia N; Byhardt RW; Shin KH; Emami B; Perez CA
    Int J Radiat Oncol Biol Phys; 1991 Jan; 20(1):7-12. PubMed ID: 1847128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized phase II chemotherapy and radiotherapy trial for patients with locally advanced inoperable non-small-cell lung cancer: long-term follow-up of RTOG 92-04.
    Komaki R; Seiferheld W; Ettinger D; Lee JS; Movsas B; Sause W
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):548-57. PubMed ID: 12062596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant boost radiation therapy for inoperable non-small-cell lung cancer: preliminary report of a prospective randomized study.
    Sun LM; Leung SW; Wang CJ; Chen HC; Fang FM; Huang EY; Hsu HC; Yeh SA; Hsiung CY; Huang DT
    Int J Radiat Oncol Biol Phys; 2000 May; 47(2):413-8. PubMed ID: 10802368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase III comparison of radiation therapy with or without recombinant beta-interferon for poor-risk patients with locally advanced non-small-cell lung cancer (RTOG 93-04).
    Bradley JD; Scott CB; Paris KJ; Demas WF; Machtay M; Komaki R; Movsas B; Rubin P; Sause WT
    Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1173-9. PubMed ID: 11955727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction cisplatin/vinblastine and irradiation vs. irradiation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/ECOG 4588. Radiation Therapy Oncology Group. Eastern Cooperative Oncology Group.
    Komaki R; Scott CB; Sause WT; Johnson DH; Taylor SG; Lee JS; Emami B; Byhardt RW; Curran WJ; Dar AR; Cox JD
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):537-44. PubMed ID: 9336129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III study of accelerated radiotherapy with and without carboplatin in nonsmall cell lung cancer: an interim toxicity analysis of the first 100 patients.
    Ball D; Bishop J; Smith J; Crennan E; O'Brien P; Davis S; Ryan G; Joseph D; Walker Q
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):267-72. PubMed ID: 7836079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gross tumor volume, critical prognostic factor in patients treated with three-dimensional conformal radiation therapy for non-small-cell lung carcinoma.
    Bradley JD; Ieumwananonthachai N; Purdy JA; Wasserman TH; Lockett MA; Graham MV; Perez CA
    Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):49-57. PubMed ID: 11777621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does additional brachytherapy improve the effect of external irradiation? A prospective, randomized study in central lung tumors.
    Huber RM; Fischer R; Hautmann H; Pöllinger B; Häussinger K; Wendt T
    Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):533-40. PubMed ID: 9231677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can serum markers be used to predict acute and late toxicity in patients with lung cancer? Analysis of RTOG 91-03.
    Hartsell WF; Scott CB; Dundas GS; Mohiuddin M; Meredith RF; Rubin P; Weigensberg IJ
    Am J Clin Oncol; 2007 Aug; 30(4):368-76. PubMed ID: 17762437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II study to evaluate accelerated fractionation via concomitant boost for squamous, adeno, and large cell carcinoma of the lung: report of Radiation Therapy Oncology Group 84-07.
    Byhardt RW; Pajak TF; Emami B; Herskovic A; Doggett RS; Olsen LA
    Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):459-68. PubMed ID: 8390420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypofractionated Image-guided Radiation Therapy (3Gy/fraction) in Patients Affected by Inoperable Advanced-stage Non-small Cell Lung Cancer After Long-term Follow-up.
    Agolli L; Valeriani M; Bracci S; Nicosia L; DE Sanctis V; Enrici RM; Osti MF
    Anticancer Res; 2015 Oct; 35(10):5693-700. PubMed ID: 26408745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.